Published in World J Gastroenterol on August 21, 2012
"Weighing the risk": Obesity and outcomes following liver transplantation. World J Hepatol (2015) 0.76
Associations between longer habitual day napping and non-alcoholic fatty liver disease in an elderly Chinese population. PLoS One (2014) 0.75
Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease. World J Gastroenterol (2016) 0.75
A clinical perspective of the link between metabolic syndrome and hepatocellular carcinoma. J Hepatocell Carcinoma (2015) 0.75
Pediatric Nonalcoholic Fatty Liver Disease: A Report from the Expert Committee on Nonalcoholic Fatty Liver Disease (ECON). J Pediatr (2016) 0.75
Prevalence of overweight and obesity in the United States, 1999-2004. JAMA (2006) 72.59
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med (1996) 22.46
Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer (1954) 12.77
Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology (2003) 8.75
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther (2011) 7.91
The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol (2005) 4.65
Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis (2005) 4.51
Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med (2010) 4.14
Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology (2011) 3.57
Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology (2004) 3.30
The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol (2003) 3.04
Nonalcoholic fatty liver disease: a review of current understanding and future impact. Clin Gastroenterol Hepatol (2004) 2.28
Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Hepatol (2002) 1.70
Patients with NASH and cryptogenic cirrhosis are less likely than those with hepatitis C to receive liver transplants. Clin Gastroenterol Hepatol (2011) 1.57
Recurrence of nonalcoholic steatohepatitis following liver transplantation. Transplantation (1996) 1.44
Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease. Liver Transpl (2001) 1.38
Nonalcoholic fatty liver disease and liver transplantation. Liver Transpl (2006) 1.16
Outcome after liver transplantation for NASH cirrhosis. Am J Transplant (2009) 1.07
Increased risk of severe recurrence of hepatitis C virus in liver transplant recipients of donation after cardiac death allografts. Transplantation (2011) 1.03
Surgical outcomes for hepatocellular carcinoma in nonalcoholic fatty liver disease. J Gastrointest Surg (2011) 1.01
Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation. Hum Pathol (2002) 0.95
Comparative allograft histology after liver transplantation for cryptogenic cirrhosis, alcohol, hepatitis C, and cholestatic liver diseases. Transplantation (2000) 0.91
Recurrence of non-viral liver disease after orthotopic liver transplantation. Liver Int (2011) 0.80
Histological study on the resemblance and difference between non-alcoholic steatohepatitis (NASH) and alcoholic liver diseases (ALD). Alcohol Clin Exp Res (2005) 0.79
Role of liver biopsy in the assessment of non-alcoholic fatty liver disease. Eur J Gastroenterol Hepatol (2004) 0.79
Nonalcoholic fatty liver disease (NAFLD)--two decades later: are we smarter about its natural history? Am J Gastroenterol (2003) 0.78
Adverse events among medical patients after discharge from hospital. CMAJ (2004) 7.89
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med (2015) 3.00
Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Nat Med (2005) 2.67
Inferior survival in liver transplant recipients with hepatocellular carcinoma receiving donation after cardiac death liver allografts. Liver Transpl (2013) 2.03
Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection. Hepatology (2010) 2.02
Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation. Liver Transpl (2009) 1.69
National recommendations for donation after cardiocirculatory death in Canada: Donation after cardiocirculatory death in Canada. CMAJ (2006) 1.68
Liver transplant outcomes in HIV-infected patients: a systematic review and meta-analysis with synthetic cohort. AIDS (2011) 1.61
Burden of disease and cost of chronic hepatitis C infection in Canada. Can J Gastroenterol Hepatol (2014) 1.59
Prospective study of clinical and histological safety of pure and uncontaminated Canadian oats in the management of celiac disease. JPEN J Parenter Enteral Nutr (2011) 1.56
Results of lis2t, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantation. Transplantation (2004) 1.51
Calcineurin inhibitor-free mycophenolate mofetil/sirolimus maintenance in liver transplantation: the randomized spare-the-nephron trial. Liver Transpl (2013) 1.46
Retrospective analysis of disease association and outcome in histologically confirmed ischemic colitis. J Dig Dis (2013) 1.43
Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transpl (2004) 1.42
Representing complexity well: a story about teamwork, with implications for how we teach collaboration. Med Educ (2012) 1.38
Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence. Liver Transpl (2007) 1.27
Percutaneous liver biopsy practice patterns among Canadian hepatologists. Can J Gastroenterol (2013) 1.15
Organ donation after cardiac death: donor and recipient outcomes after the first three years of the Ontario experience. Can J Anaesth (2011) 1.10
Infarct-like necrosis: a distinct form of necrosis seen in colorectal carcinoma liver metastases treated with perioperative chemotherapy. Am J Surg Pathol (2012) 1.10
Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis. J Hepatol (2011) 1.09
The role of anti-non-Gal antibodies in the development of acute humoral xenograft rejection of hDAF transgenic porcine kidneys in baboons receiving anti-Gal antibody neutralization therapy. Transplantation (2006) 1.03
Increased risk of severe recurrence of hepatitis C virus in liver transplant recipients of donation after cardiac death allografts. Transplantation (2011) 1.03
Effect of a nurse team coordinator on outcomes for hospitalized medicine patients. Am J Med (2005) 1.02
Defining readmission risk factors for liver transplantation recipients. Gastroenterol Hepatol (N Y) (2011) 1.01
Inhibition of Cdc25A suppresses hepato-renal cystogenesis in rodent models of polycystic kidney and liver disease. Gastroenterology (2011) 1.00
Upper gastrointestinal and intra-abdominal hemorrhage secondary to diffuse large B-cell gastric lymphoma. Can J Surg (2008) 0.98
Perioperative neurological complications after liver transplantation are best predicted by pre-transplant hepatic encephalopathy. Neurocrit Care (2008) 0.98
Association of recanalization of the left umbilical vein with umbilical hernia in patients with liver disease. Liver Transpl (2005) 0.97
A novel in vivo siRNA delivery system specifically targeting liver cells for protection of ConA-induced fulminant hepatitis. PLoS One (2012) 0.94
Outcome of surgical complications following simultaneous pancreas-kidney transplantation. Nephrol Dial Transplant (2011) 0.92
Does robotic assistance improve efficiency in performing complex minimally invasive surgical procedures? Surg Endosc (2009) 0.92
Outcomes of peginterferon alpha-2a and ribavirin hepatitis C therapy in Aboriginal Canadians. Can J Gastroenterol (2008) 0.91
Long-term outcomes of emergency liver transplantation for acute liver failure. Liver Transpl (2009) 0.91
Updated thresholds for alanine aminotransferase do not exclude significant histological disease in chronic hepatitis C. Liver Int (2011) 0.90
Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard-dose or reduced-dose tacrolimus in liver transplant recipients. Liver Transpl (2009) 0.89
Stem cells and their role in renal ischaemia reperfusion injury. Am J Nephrol (2012) 0.87
Should peritoneal dialysis catheters be removed at the time of kidney transplantation? Can Urol Assoc J (2012) 0.87
Yo Jyo Hen Shi Ko (YHK) improves transaminases in nonalcoholic steatohepatitis (NASH): a randomized pilot study. Dig Dis Sci (2006) 0.86
Prospective evaluation of the role of quantitative Doppler ultrasound surveillance in liver transplantation. Liver Transpl (2004) 0.86
Elective and emergency abdominal surgery in patients 90 years of age or older. Can J Surg (2012) 0.86
Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up. Liver Transpl (2003) 0.85
Transient elastography in Canada: Current state and future directions. Can J Gastroenterol Hepatol (2015) 0.85
Kidney transplantation in HIV-positive adults: the UK experience. Int J STD AIDS (2013) 0.84
Long-term results of pediatric liver transplantation in a combined pediatric and adult transplant program. CMAJ (2002) 0.83
Re-directing an alkylating agent to mitochondria alters drug target and cell death mechanism. PLoS One (2013) 0.83
Improvement in human decay accelerating factor transgenic porcine kidney xenograft rejection with intravenous administration of gas914, a polymeric form of alphaGAL. Transplantation (2003) 0.83
Hepatic metastasis from adrenocortical carcinoma fifteen years after primary resection. Saudi J Gastroenterol (2012) 0.81
Tacrolimus as intervention in the treatment of hyperlipidemia after liver transplant. Transplantation (2006) 0.81
Anonymous pilot study of hepatitis C virus prevalence in liver transplant surgeons. Liver Transpl (2006) 0.81
Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid. Transplantation (2007) 0.80
Spontaneous regression of a large hepatocellular carcinoma: case report. Ger Med Sci (2011) 0.80
Recipient ineligibility after liver transplantation assessment: a single centre experience. Can J Surg (2013) 0.80
Out with the old and in with the new: hepatic fibrosis assessment in Canada. Can J Gastroenterol Hepatol (2014) 0.80
Do older patients utilize excess health care resources after liver transplantation? Ann Hepatol (2011) 0.79
Reduction of liver ischemia reperfusion injury by silencing of TNF-α gene with shRNA. J Surg Res (2011) 0.78
Safety and antiviral activity of albinterferon alfa-2b dosed every four weeks in genotype 2/3 chronic hepatitis C patients. Clin Gastroenterol Hepatol (2008) 0.78
Increased duration of dual pegylated interferon and ribavirin therapy for genotype 1 hepatitis C post-liver transplantation increases sustained virologic response: a retrospective review. Saudi J Gastroenterol (2013) 0.78
Lobular capillary hemangioma of the liver. Hepatobiliary Pancreat Dis Int (2009) 0.78
Liver transplantation for alcoholic liver disease among Canadian transplant centres: a national study. Can J Gastroenterol (2013) 0.78
The trientine crisis in Canada: a call to advocacy. Can J Gastroenterol Hepatol (2014) 0.78
Pancreatic transplantation: surgical technique, normal radiological appearances and complications. Insights Imaging (2010) 0.77
The effect of liver transplantation for primary sclerosing cholangitis on disease activity in patients with inflammatory bowel disease. Gastroenterol Hepatol (N Y) (2013) 0.77
Comparison of short- and long-term outcomes after early versus late liver retransplantation: a single-center experience. J Surg Res (2013) 0.77
The long-term survival of baboon-to-monkey kidney and liver xenografts. Xenotransplantation (2003) 0.76
Kidney and liver transplants from donors after cardiac death: initial experience at the London Health Sciences Centre. Can J Surg (2010) 0.76
A pilot study of vitamin E for the treatment of cirrhotic muscle cramps. Liver Int (2011) 0.76
Evaluation of the updated definition of early allograft dysfunction in donation after brain death and donation after cardiac death liver allografts. Hepatobiliary Pancreat Dis Int (2012) 0.76
Interobserver variability in assessing dysplasia and architecture in colorectal adenomas: a multicentre Canadian study. J Clin Pathol (2014) 0.76
Changing donor characteristics in liver transplantation over the last 10 years in Canada. Liver Transpl (2013) 0.76